Complications associated with intestinal infusion therapies in patients with Parkinson’s disease: a single-center retrospective study and 15-year experience

IntroductionParkinson’s disease (PD) is a progressive neurodegenerative disorder, in advanced stages characterized by motor and non-motor fluctuations, significantly impacting patients’ quality of life (QoL). Advanced therapies, such as levodopa/carbidopa intestinal gel or carbidopa/levodopa enteral...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής

Κύριοι συγγραφείς:	Igor Straka, Zuzana Andre, Zuzana Kosutzka, Karin Gmitterova, Milos Stevove, Zuzana Durkovicova, Radovan Juricek, Peter Valkovic, Michal Minar
Μορφή:	Artigo
Γλώσσα:	Inglês
Έκδοση:	Frontiers Media S.A. 2025-05-01
Σειρά:	Frontiers in Neurology
Θέματα:	advanced Parkinson’s disease adverse events gastrojejunostomy levodopa/carbidopa intestinal gel (LCIG) levodopa/entacapone/carbidopa intestinal gel (LECIG)
Διαθέσιμο Online:	https://www.frontiersin.org/articles/10.3389/fneur.2025.1547557/full
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!